๐๏ธ Fundamental Ethical Principle
Laws and legal orders "take priority" over ethics when conflicts arise
Autonomy
Respect for patient decision-making
Beneficence
Acting in patient's best interest
Nonmaleficence
"Do no harm"
Justice
Fair distribution of benefits
๐ Major Ethical Scenarios in Genetic Counseling
๐งฌ Genetic Testing Issues
- Use of genetic information by employers and insurers
- Preimplantation genetic testing for non-medical traits
- Testing children for adult-onset conditions
- Incidental and secondary findings
- Late-term abortion decisions
๐ Privacy & Information Issues
- Informed consent complexities
- Research ethics and participation
- Duty to warn vs. patient confidentiality
- Direct-to-consumer genetic testing
- Forensic use of genetic information
- Patenting and ownership of genetic data
๐๏ธ Four Major Federal Laws/Regulations
๐งฌ GINA (2008)
Genetic Information Nondiscrimination Act
Protects against genetic discrimination in health insurance and employment
๐ฅ ACA (2010)
Affordable Care Act
Pre-existing condition protections and expanded coverage
๐ HIPAA (1996)
Health Insurance Portability and Accountability Act
Privacy, Security, and Breach Notification rules
๐ฌ Common Rule (1974/1991)
45 CFR 46 - Protection of Human Subjects
Research ethics, IRBs, vulnerable populations, informed consent
๐งฌ Genetic Information Nondiscrimination Act (GINA) - 2008
Core Protections
- Prohibits genetic discrimination in health insurance and employment
- Covers genetic testing results AND family history
- Includes fetal, embryonic, and clinical research genetic information
What GINA Prohibits
- Health insurers using genetic data for eligibility/premiums
- Employers using genetic info for hiring/firing
- Mandated genetic data disclosure in employment
โ ๏ธ Key GINA Exceptions ("What GINA Does NOT Cover")
Manifest Conditions
Does not apply to people who already have symptoms/diagnosis
Insurance Types
Life, disability, or long-term care insurance can still use genetic information
Small Employers
Companies with <15 employees are exempt
Military & Routine Tests
Military exempt; routine labs (CBC, cholesterol) not protected
๐งช Genetic vs Non-Genetic Tests
| Test Type | Examples | GINA Protected |
|---|---|---|
| Genetic Tests | BRCA1/BRCA2, Whole exome sequencing, Gene panels, Chromosomal microarray, Enzyme activity assays | โ Protected |
| Non-Genetic Tests | Complete blood count (CBC), Cholesterol, Liver function, Urine drug screen, Blood glucose | โ Not Protected |
๐ก "Watercooler Exception"
If an employer accidentally acquires genetic information (e.g., overhearing family history), they are not liable unless they intentionally sought this information.
๐ฅ Affordable Care Act (ACA) - 2010
Pre-existing Condition Protections
- Prohibits denial of coverage based on health history
- Eliminates lifetime and annual coverage caps
- Mandates essential health benefits
- Requires large employers to provide insurance
- Extended Medicaid and marketplace subsidies
Key ACA Provisions
- Expanded Coverage: Medicaid expansion and marketplaces
- Subsidies: Financial aid for insurance (100%-400% poverty line)
- Essential Benefits: Core services including mental health
- Employer Mandate: Large employers must insure workers
- No Lifetime Limits: Eliminated coverage caps
๐ Key Insight: Protection Gaps
GINA's protections do NOT apply to "survivors" (people with pre-existing conditions) - they only apply to previvors (before symptoms appear). This is why both ACA and GINA are needed for comprehensive protection.
โ๏ธ GINA vs ACA: Protection Comparison
๐ Previvors vs Survivors Protection
| Population Type | ACA Protection | GINA Protection | Life/Disability Insurance |
|---|---|---|---|
| Previvors (asymptomatic carriers) |
โ Yes | โ Yes | โ No Protection |
| Survivors (people with existing conditions) |
โ Yes | โ No | โ No Protection |
๐ Detailed Law Comparison
| Aspect | GINA (2008) | ACA (2010) |
|---|---|---|
| Primary Focus | Genetic discrimination prevention | Healthcare access and affordability |
| Health Insurance | Protects against genetic discrimination in eligibility/premiums | Prohibits denial for pre-existing conditions |
| Employment | Prohibits genetic discrimination in hiring/firing | Employer mandate for large companies |
| Coverage Scope | Genetic information & family history only | All health conditions and medical history |
| Manifest Conditions | Does NOT protect | Full protection |
| Life/Disability Insurance | No protection | No protection |
| Company Size Limit | 15+ employees only | 50+ employees for mandate |
๐ก Why Both Laws Are Essential
- GINA: Protects healthy people with genetic predispositions from discrimination
- ACA: Protects people with existing conditions from being denied coverage
- Together: They provide comprehensive protection across the health spectrum
- Gap: Neither protects life, disability, or long-term care insurance
๐งฌ GINA's Unique Value
- Prevents "genetic underclass" formation
- Encourages genetic testing participation
- Protects family history information
- Covers employment discrimination
๐ฅ ACA's Broader Protection
- Protects all pre-existing conditions
- Eliminates lifetime coverage limits
- Expands access through Medicaid
- Mandates essential health benefits
๐ Health Insurance Portability and Accountability Act (HIPAA) - 1996
Three Main Components
๐ Privacy Rule
- Protects individually identifiable health information (PHI)
- Applies to all PHI, not just electronic
- Covers "covered entities" and "business associates"
18 Personal Identifiers: Names, addresses, birth dates, phone numbers, email, SSN, medical record numbers, >3-digit ZIP codes, IP addresses, biometric identifiers, full face photos, etc.
๐ก๏ธ Security Rule
Only applies to electronic PHI (e-PHI)
- Administrative: Security personnel, access management, workforce training
- Physical: Facility access control, workstation security
- Technical: Access control, audit controls, integrity, transmission security
๐ฏ Most Critical: Role-based Access
Ensures e-PHI access granted only based on user's role within organization
๐จ Breach Notification Rule
- Notification when unsecured/unencrypted PHI accessed without permission
- Must notify patients within 60 days
- Must notify media if >500 people affected
๐ Patient Rights: Designated Record Set (DRS)
What's Included in DRS
- Healthcare providers: Medical records, clinical notes, billing, test results
- Health insurers: Enrollment files, claims data, payment records
Exception: DRS does NOT include psychotherapy notes
Patient Rights
- View, copy, and review health information
- Request changes to inaccurate records
- Ask for disclosure history
- Receive information in alternate formats
- File complaints for violations
๐ฅ HIPAA "Treatment" Exception for Record Transfer
๐ Continuation of Care Transfers
When providers can share PHI without additional patient consent:
- Referrals: Patient agrees to referral = implied consent for necessary record transfer
- Provider-to-provider communication: For treatment coordination
- Continuation of care: Part of ongoing medical treatment
๐ฏ Key Point: TPO Rule
HIPAA allows PHI sharing without patient authorization for Treatment, Payment, Operations (TPO). When a patient agrees to a referral, transferring necessary medical records falls under "Treatment" - no additional consent required by federal law (though institutional policies may differ).
โ ๏ธ HIPAA Violation Penalties
Civil Penalties
- Minimum $100, up to $25,000 per year if unaware
- Plus corrective action plans
Criminal Penalties
- Basic violation: Up to $50,000 and 1 year prison
- False pretenses: Up to $100,000 and 5 years
- Commercial/malicious: Up to $250,000 and 10 years
๐ฌ Research Ethics Foundation
๐ Legal Framework Hierarchy
๐๏ธ Federal Law
National Research Act of 1974
Established a commission to identify basic ethical principles for research (became the Belmont Report)
Motivated by the Tuskegee untreated syphilis study
๐ Federal Regulation
45 CFR 46 "Protection of Human Subjects"
Includes the Common Rule (establishes IRBs & informed consent) and the Belmont Report (ethical principles)
๐ฌ The Common Rule (45 CFR 46)
๐ Definition: "Common Rule" = Consent & Review Board
Federal regulation establishing informed consent requirements, IRBs, and scope of human research subject protections
๐ Subpart A: Common Rule
Protection of Human Research Subjects - establishes informed consent, IRBs, and scope of protections (including exceptions)
๐คฑ Subpart B: Babies
Additional protections for pregnant women, human fetuses, and neonates involved in research
๐ Subpart C: Captives
Additional protections pertaining to biomedical and behavioral research involving prisoners as subjects
๐ถ Subpart D: Kids
Additional protections for children involved as subjects in research
๐ Subpart E: Registration
Registration of Institutional Review Boards (IRBs)
๐๏ธ Belmont Report: Ethical Principles
โ๏ธ Justice
Fair distribution of research benefits and burdens. Who bears the risks vs. who receives the benefits?
๐ณ๏ธ Autonomy
Respect for persons - individuals should be treated as autonomous agents capable of making their own decisions
โค๏ธ Beneficence
Maximize benefits and minimize harms. Do good and avoid harm to research participants
๐ฌ What IS and ISN'T Human Subjects Research
โ Human Subjects Research
Human subject: Living individual about whom investigator obtains information/biospecimens through intervention/interaction OR obtains identifiable private information/biospecimens
Research: Systematic investigation designed to develop or contribute to generalizable knowledge
โ NOT Human Subjects Research
- Scholarly activities: Oral history, journalism, biography, literary criticism, legal research
- Public health surveillance: Activities by public health authorities
- Criminal justice activities: Authorized by law or court order for criminal justice purposes
๐ฅ IRB (Institutional Review Board)
Found at each institution that conducts clinical research. Responsible for protecting the safety of research participants and ensuring studies are ethical. Reviews and approves research protocols before studies can begin.
๐ฅ Vulnerable Populations in Research
โ ๏ธ Key Concept: Why Special Protection?
Vulnerable populations receive special consideration due to increased likelihood of coercion/undue influence. Be careful with paying people for research participation, especially protected groups like prisoners.
| Vulnerable Population | Protection Status | Special Considerations |
|---|---|---|
| Children | Vulnerable | Subpart D protections, assent + parental consent |
| Prisoners | Vulnerable | Subpart C protections, coercion concerns |
| Mentally Disabled | Vulnerable | Impaired decision-making capacity |
| Economically Disadvantaged | Vulnerable | Potential for undue influence |
| Educationally Disadvantaged | Vulnerable | May not fully understand research risks/benefits |
| Individuals with Impaired Decision-Making Capacity | Vulnerable | Cannot provide truly informed consent |
๐ Common Rule Subparts for Vulnerable Groups
๐คฑ Subpart B: Pregnant Women, Fetuses, and Neonates
- Additional protections during pregnancy and neonatal period
- Research must have minimal risk to fetus
- Both maternal and paternal consent may be required
- Independent assessment of research risks
๐ Subpart C: Prisoners
- Heightened vulnerability due to institutional setting
- Coercion concerns from prison authorities
- Limited ability to withdraw from studies
- Special IRB composition requirements
- Restricted types of permissible research
๐ถ Subpart D: Children
- Cannot provide legal consent (requires parental permission)
- Must provide "assent" when developmentally appropriate
- Research risk must be justified by potential benefit
- Special consideration for adolescents approaching adulthood
๐ฏ Key Vulnerability Factors
๐ง Cognitive Factors
- Impaired decision-making: Mental illness, cognitive disability
- Developmental limitations: Children, adolescents
- Educational barriers: Limited education affecting comprehension
- Language barriers: Non-native speakers
๐ฐ Economic Factors
- Financial desperation: May accept risks for payment
- Healthcare access: May participate to receive free care
- Employment concerns: Workplace-based recruitment
- Insurance limitations: Uninsured populations
๐๏ธ Institutional Factors
- Captive populations: Prisoners, nursing home residents
- Authority relationships: Students, employees
- Healthcare dependence: Patients dependent on provider
- Limited autonomy: Institutional control over decisions
๐ฅ Medical Factors
- Severe illness: Desperation for treatment options
- Treatment-refractory conditions: No other options available
- Life-threatening conditions: May take excessive risks
- Chronic pain/suffering: May compromise judgment
๐ก๏ธ Special Protections for Vulnerable Populations
- Enhanced IRB review: More careful evaluation of risks/benefits
- Additional consent safeguards: Witness requirements, simplified language
- Independent advocates: Someone representing participant's interests
- Ongoing monitoring: Regular check-ins during study participation
- Alternative recruitment: Avoiding coercive environments
- Fair payment policies: Reasonable compensation, not excessive incentives
โ ๏ธ Critical Research Ethics Issues
โ๏ธ Coercion vs. Undue Influence: Critical Distinctions
| Aspect | Coercion | Undue Influence |
|---|---|---|
| Definition | Employing force, threats, or intimidation to compel participation against participant's will | Applying excessive persuasion (often financial) that exploits participant's trust or vulnerable position |
| Impact on Consent | Renders participant's consent invalid | Compromises the voluntary nature of consent |
| Legal Status | Unlawful | Ethically problematic, not unlawful |
| Example | Threatening to withhold standard medical treatment unless patient agrees to participate | Offering substantial financial compensation to participant in desperate financial situation for risky study |
๐ญ Deception in Research
๐ What is Deception?
Definition: Intentionally misleading or withholding information from research participants about the true purpose or potential risks of a study
Example: Telling participants they performed poorly on a math exam (regardless of actual performance) to study effects of negative feedback on physiological responses
โ When Acceptable
- Certain psychology research contexts
- When knowledge of true purpose would influence participant behavior
- Necessary to answer the research question
- Cannot involve significant undisclosed risks
๐ Requirements When Using Deception
- IRB approval required - deception must be justified
- Minimize deception - only what's necessary
- Debriefing mandatory - explain true purpose after study
- Allow data withdrawal after debriefing
๐ Conflicts of Interest in Research
๐ผ Types of Conflicts
Financial: Stock ownership, consulting fees, patents, research funding from interested companies
Personal: Family relationships, friendships affecting objectivity
Example: Researcher owning Pfizer stock while conducting Pfizer-sponsored clinical trial
โ ๏ธ Why Problematic
- May bias study design decisions
- Can influence data interpretation
- May affect adverse event reporting
- Could impact publication of results
- Participants deserve to know about potential bias
๐ก๏ธ Management Requirements
- Must disclose to IRB during approval process
- May need disclosure to participants in consent
- Must disclose in publications
- Independent oversight may be required
- Severe cases: Researcher may need to withdraw
๐ฅ Research Integrity Issues
๐ฅ Therapeutic Misconception
Definition: When a research participant or investigator inaccurately attributes therapeutic intent to research procedures
In other words: Patient thinks that by enrolling in a research study, they will clinically improve
High risk situations: Progressive/degenerative conditions (ALS) or treatment-refractory conditions (metastatic cancer, treatment-resistant schizophrenia)
๐ Protocol Deviations
Definition: When an investigator does not implement or follow some aspect of a research study as approved by the IRB
Example: Enrolling a participant who did not meet all the inclusion criteria for a study
Impact: Compromises study validity and participant safety
๐ซ Research Misconduct
Definition: Fabrication, falsification, or plagiarism in proposing, performing, reviewing research, or reporting research results
Examples: Making up data, falsifying results, stealing research ideas
Consequences: Career-ending violations of research integrity
๐ Privacy Violations in Research
Definition: Unauthorized access, use, or disclosure of a research subject's personal information
Examples: Sharing participant data without consent, inadequate data security
Related to: HIPAA violations but specific to research contexts
โ ๏ธ Managing Therapeutic Misconception
When enrolling patients with treatment-refractory or progressive conditions, investigators may need to:
- Hire a research ethicist to witness the consent process
- "Curb the enthusiasm" that both patient and clinician express about participation
- Clearly distinguish between research goals and therapeutic goals
- Emphasize uncertainty about research outcomes
- Ensure understanding that research participation may not provide clinical benefit
๐ฏ Core Question for Any Research Scenario
"Does this practice preserve the participant's ability to make a truly free, informed decision about participation?"
If the answer is no due to coercion, undue influence, inappropriate deception, or unmanaged conflicts of interest, then the research design needs modification to protect participants' rights and welfare.
๐ฅ Genetic Counselor Conflicts of Interest
๐ COI Definition for Genetic Counselors (NSGC Guidelines)
A COI is a set of conditions where professional duties/judgment concerning a primary interest (e.g., employment, patient welfare) can be influenced by bias and harm caused by a conflicting secondary interest (e.g., financial gain).
๐ฏ Why COI Matters to Genetic Counselors
๐ก Key Insights
- Many GCs have COI - the challenge is to recognize, assess, and manage it
- Having a COI is common - every profession has primary interests and everyone has secondary interests
- JAMA 2017: "An individual's conflict of interest is not tantamount to saying their judgment is affected, nor does it constitute an accusation of bias or prejudgment"
โ ๏ธ Professional Obligations
- Professional obligation to provide objective health information to patients
- Harmful COI can compromise professional judgment and patient care
- Trust issues - can erode relationships with colleagues, healthcare system, and society
๐จ When COI Becomes Problematic
Two conditions must be met:
- Risk that secondary interest will bias individual's judgment with respect to primary interests
- This bias will cause harm to primary interests
Note: Some biases may be subconscious/unconscious, making them difficult to identify and manage
๐ฏ Four Types of COI for Genetic Counselors
๐ฐ Financial COI
Putting personal financial interests over the interests of the organization
Examples: Stock ownership, consulting fees, speaking honoraria, gifts from companies
๐ Professional COI
Awarding jobs or promotions based on preference rather than qualifications
Examples: Hiring friends, preferential treatment in academic settings
๐จโ๐ฉโ๐งโ๐ฆ Personal COI
Prioritizing loyalty to friends and family when making professional decisions
Examples: Referring patients to family members, favoritism toward colleagues
๐ Contractual COI
Partaking in contractual work on behalf of a direct competitor
Examples: Working for competing genetic testing companies, consulting for competitors
๐ ๏ธ The "4 D's" Approach to Managing COI
A useful approach to managing conflicts of interest:
- Disclose: Make the conflict known to relevant parties
- Distance: Create separation between conflicting interests
- Delegate: Have someone else handle decisions where conflict exists
- Disassociate: Remove yourself from the conflicting situation entirely
โ๏ธ Anti-Kickback Statute & Stark Law
๐จ Why This Matters to Genetic Counselors
Healthcare providers (including genetic counselors) are attractive targets for kickback schemes because they control referrals for genetic tests, specialist consultations, and other healthcare services. Many companies want your patients' business and may offer incentives to influence your referral patterns.
๐๏ธ Anti-Kickback Statute
Definition: Federal criminal law that prohibits offering, paying, soliciting, or receiving anything of value to induce or reward referrals for items or services covered by federal healthcare programs (like Medicare and Medicaid).
Key Aspects:
- Applies to all healthcare providers who can arrange or recommend medical services
- Covers any item or service paid by federal healthcare programs
- Intent must be proved - must show something was knowingly and willfully provided to induce referrals
- Criminal and civil penalties - up to $25,000 fine + 5 years prison
- Designed to prevent corruption of medical decision-making through financial incentives
Example: Genetic counselor receives $20 gift cards for each test ordered โ Payment for referrals (violation)
โ๏ธ Stark Law
Definition: Federal civil law that prohibits physician referrals to entities where they have financial relationships, for specific "designated health services" when Medicare/Medicaid pays.
Key Aspects:
- Applies to physicians only
- Physician referrals to entities where they have financial relationships
- Strict liability - no intent required
- Specific "designated health services" when Medicare/Medicaid pays
- Focuses on ownership/investment interests
- Civil monetary penalties, refunds, exclusion
๐ Anti-Kickback Statute vs Stark Law Comparison
| Aspect | Anti-Kickback Statute | Stark Law |
|---|---|---|
| Who it applies to | All medical providers who can arrange/recommend services | Only physicians |
| What it prohibits | Offering, paying, soliciting, or receiving anything of value to induce referrals | Physician referrals to entities where they have financial relationships |
| Intent requirement | Intent must be proved - knowingly & willfully provided to induce referrals | Strict liability - no intent required |
| Coverage | Any item/service for federal healthcare programs | Specific "designated health services" when Medicare/Medicaid pays |
| Financial relationships | Focuses on payments/kickbacks for referrals | Focuses on ownership/investment interests |
| Penalties | Criminal: $25K + 5 years prison Civil: $50K + 3x damages |
Civil monetary penalties, refunds, exclusion |
๐ฏ Why Both Laws Exist
- Anti-Kickback Statute: Prevents corruption through payments/bribes
- Stark Law: Prevents conflicts of interest through ownership/financial relationships
Both laws work together to ensure medical decisions are based on patient need, not financial gain.
๐จ Red Flags for Genetic Counselors
๐ซ Coercion Indicators
- Threats to withhold treatment
- Institutional pressure in hospital settings
- Time pressure ("must decide now")
- Authority figures applying pressure
๐ฐ Undue Influence Indicators
- Excessive payment relative to economic status
- Targeting financially desperate populations
- Emphasizing payment over risks in recruitment
- Exploiting vulnerable circumstances
๐ญ Deception Problems
- Hiding significant risks from participants
- No debriefing plan in place
- Deception about procedures affecting willingness
- Unnecessary deception for research question
๐ Research COI Issues
- Undisclosed financial relationships
- Researcher personally benefits from outcomes
- Lack of independent oversight
- Conflicts not mentioned in consent forms
๐ฅ Genetic Counselor COI Signs
- Accepting gifts from genetic testing companies
- Financial relationships affecting patient referrals
- Personal relationships influencing professional decisions
- Working for competing companies simultaneously
๐ฅ Therapeutic Misconception Signs
- Patient expressing hope for clinical improvement
- Excessive enthusiasm about study participation
- Treatment-refractory or progressive conditions
- Confusion between research and treatment goals
๐ฅ Clinical Applications & Legal Scenarios
โ๏ธ Medical Malpractice in Genetic Counseling
๐ Case Study: CFTR Carrier Screening Negligence
Scenario: Mother is confirmed CFTR carrier. Genetic counselor tells family "not to worry about risk" because father is Black (racial assumption). Baby born with cystic fibrosis. Father later confirmed carrier. Parents state: "Would never have had children if we knew the risk."
Legal Finding: Medical negligence - failure to follow standard of care by not testing the father.
๐ฏ The "4 D's" of Medical Negligence
1. ๐ Duty
Healthcare provider has legal obligation to provide competent care according to professional standards
2. ๐ซ Deviation
Provider failed to meet standard of care (what reasonable professional would do in same situation)
3. ๐ Damages
Actual harm or injury resulted from the provider's actions or inaction
4. ๐ Direct Cause
Provider's failure directly caused the harm (but-for causation)
๐จ Common Genetic Counseling Negligence Areas
๐ Failure to Act Examples
- Not taking adequate family history
- Not ordering appropriate genetic tests
- Not identifying high-risk situations
- Not following up on abnormal results
โ Information Misuse Examples
- Failure to recognize genetic disorder in child
- Misdiagnosis or ordering wrong test
- Misinterpretation of laboratory results
- Providing incorrect recurrence risks
๐ก๏ธ Protection Strategy: Documentation
Always document any deviations from standard care! For example, if a patient refuses recommended genetic testing, document this refusal thoroughly. This helps protect against future malpractice claims by showing informed patient choice rather than provider negligence.
๐ Malpractice Statistics
Most medical malpractice cases result from real or perceived negligence. In genetics, suits are usually based on claims that providers either did not use or misused information/techniques.
โ๏ธ Legal vs Other Classifications
- Medical Battery: Unwanted procedures without consent
- Diagnostic Error: Wrong/missed diagnosis
- Provider Impairment: Under influence of substances
โ When Disclosure is Permitted Without Patient Consent
- Emergency situations: Prevent serious and imminent threat (rare in genetics)
- Public health activities: Disease control and prevention
- Legal proceedings: Court orders, subpoenas
- Abuse/neglect reporting: Mandated reporting to protective services
- Healthcare operations: Quality assessment, treatment between providers
- Deceased individuals: Coroners, medical examiners
๐ซ Duty to Warn vs HIPAA Privacy Rule
Current Legal Status
- Genetic counselors likely have no direct duty to warn family members
- Limited law exists with significant uncertainty
- Very rare instances might permit disclosure, but unclear legally
๐ฌ Clinical Trial and Research Considerations
Patient Access to Research Data
- Patients have HIPAA rights to access their personal health information
- However: Access to preliminary trial data may be restricted to protect study integrity
- Must balance individual access rights with research protections and other participants' privacy
- Patients should be informed about data access limitations during consent process
- Can provide information within designated record set within 30 days if requested
๐ Best Practices for Genetic Counselors
โ๏ธ Legal Compliance First
Always follow applicable laws, with ethics as secondary consideration when conflicts arise
๐ Informed Consent
Clearly explain limitations of genetic privacy protections, especially GINA exceptions
๐ Documentation
Maintain detailed records of patient decisions, especially regarding family information sharing
๐ Security Measures
Implement role-based access controls and other HIPAA Security Rule requirements for e-PHI
๐ฌ Research Ethics
When involved in research, ensure proper IRB approval and special protections for vulnerable populations. Avoid coercion and undue influence in recruitment.
๐ฐ Ethical Recruitment
Ensure payment is reasonable compensation, not exploitation. Screen for vulnerability to undue influence, especially in economically disadvantaged populations.
๐ Disclosure Requirements
Disclose any conflicts of interest to IRB and participants. Provide debriefing if deception was used in research. Maintain transparency in all professional relationships.
๐ Professional Guidelines
Follow established codes of ethics while ensuring legal compliance
๐ Continuing Education
Stay updated on evolving legal landscape in genetics - an area of active legal development
๐ฏ Standard of Care
Follow evidence-based protocols; never make assumptions based on demographics or ethnicity
๐ด Interactive Flashcards
Click on any flashcard to reveal the answer
What does GINA protect?
Genetic testing results AND family history in health insurance and employment (but NOT life, disability, or long-term care insurance)
Who is NOT protected by GINA?
People with manifest conditions (already have symptoms), employees at companies <15 people, military personnel
What's the difference between previvors and survivors under ACA/GINA?
Previvors (asymptomatic): Protected by both ACA and GINA
Survivors (with conditions): Protected by ACA but NOT GINA
What are the 3 components of HIPAA?
1. Privacy Rule (all PHI)
2. Security Rule (e-PHI only)
3. Breach Notification Rule
What's the most critical HIPAA Security Rule measure?
Role-based access control - ensuring e-PHI access is granted only based on the user's role within the organization
Do genetic counselors have a duty to warn family members?
No clear duty to warn exists. Limited law with significant uncertainty. Very rare instances might permit disclosure.
What's the "Watercooler Exception"?
If an employer accidentally acquires genetic information (e.g., overhearing), they're not liable unless they intentionally sought it
Which tests are NOT protected by GINA?
Non-genetic tests: CBC, cholesterol, liver function, urine drug screens, blood glucose tests
What are the "4 D's" of medical negligence?
1. Duty (obligation to provide competent care)
2. Deviation (from standard of care)
3. Damages (actual harm resulted)
4. Direct Cause (provider's failure caused harm)
What is medical battery?
Performing medical procedures or touching a patient without their consent. Examples: operating on wrong body part, unauthorized procedures, any unwanted physical contact during medical care.
What is provider impairment?
Healthcare provider working under the influence of drugs, alcohol, or mental illness that affects their ability to provide safe, competent care to patients.
What is the Common Rule?
Federal regulation (45 CFR 46) that establishes informed consent requirements, IRBs, and scope of human research subject protections. "Common Rule" = Consent & Review board.
What are the 3 Belmont Report principles?
1. Justice (fair distribution of benefits/burdens)
2. Autonomy (respect for persons)
3. Beneficence (maximize benefits, minimize harms)
Name 3 vulnerable populations in research?
Children, prisoners, mentally disabled persons, economically disadvantaged, educationally disadvantaged, individuals with impaired decision-making capacity - all receive special protections due to increased likelihood of coercion/undue influence.
What is NOT considered human subjects research?
Scholarly activities (journalism, biography), public health surveillance activities, and criminal justice activities authorized by law or court order.
What's the difference between coercion and undue influence?
Coercion uses threats/force and is UNLAWFUL (makes consent invalid). Undue influence uses excessive persuasion/incentives and is ethically problematic but not illegal (compromises voluntary consent).
When is deception acceptable in research?
When necessary to answer research question, knowledge of true purpose would influence behavior, no significant undisclosed risks, IRB approved, and mandatory debriefing provided after study.
What is a conflict of interest in research?
Financial or personal relationships that may bias researcher judgment. Examples: stock ownership in study sponsor, consulting fees, patents. Must be disclosed to IRB and potentially participants.
Why is paying research participants ethically concerning?
May create undue influence, especially with vulnerable populations. Financial incentives might cause participants to underestimate risks due to appeal of payment, compromising truly voluntary consent.
What is therapeutic misconception?
When research participants or investigators incorrectly believe that research procedures have therapeutic intent - that enrolling in the study will clinically improve their condition. Especially concerning with treatment-refractory conditions.
What's the difference between protocol deviation and research misconduct?
Protocol deviation: Not following IRB-approved study procedures (e.g., enrolling ineligible participant). Research misconduct: Fabrication, falsification, or plagiarism in research - much more serious violation.
What are the 4 types of COI for genetic counselors?
1. Financial (personal financial interests over organization)
2. Professional (hiring based on preference vs qualifications)
3. Personal (prioritizing friends/family in professional decisions)
4. Contractual (working for direct competitors)
What are the "4 D's" for managing conflicts of interest?
1. Disclose (make conflict known)
2. Distance (create separation)
3. Delegate (have someone else decide)
4. Disassociate (remove yourself entirely)
When does a COI become problematic for genetic counselors?
When 2 conditions are met: 1) Risk that secondary interest will bias judgment regarding primary interests, AND 2) This bias will cause harm to primary interests. Note: Some biases may be subconscious.
What made the CFTR case medical negligence?
Counselor made racial assumption instead of testing father when mother was confirmed CFTR carrier. This "failure to act" led to birth of affected child when parents would have chosen differently.
What's included in the Designated Record Set?
Medical records, clinical notes, billing info, test results (providers) + enrollment files, claims, payments (insurers). NOT psychotherapy notes
What does the Anti-Kickback Statute prohibit?
Offering, paying, soliciting, or receiving anything of value to induce or reward referrals for items/services covered by federal healthcare programs. Applies to ALL healthcare providers.
What's the difference between Anti-Kickback Statute and Stark Law?
Anti-Kickback: All providers, payment for referrals, intent required
Stark Law: Physicians only, ownership/financial relationships, strict liability (no intent required)
๐ Knowledge Quiz
Question 1
Scenario: Sam has neurofibromatosis type 1 (NF1) and multiple family members with type 2 diabetes. Which scenario would NOT be protected by GINA?
Question 2
Scenario: A 34-year-old woman in a clinical trial for sickle cell disease requests preliminary trial data. What's the best response?
Question 3
Scenario: What is the MOST critical measure for HIPAA Security Rule compliance in a genetic counseling center?
Question 4
Scenario: A 33-year-old woman with BRCA1 mutation wants to keep the information private from her sisters. The genetic counselor should:
Question 5
Scenario: Which of the following is NOT protected by GINA?
Question 6
Scenario: A 2-week-old neonate is diagnosed with cystic fibrosis. Prior to conception, his mother underwent carrier screening that was positive for a pathogenic variant in CFTR. At the time, the genetic counselor told the family "not to worry about the risk" of having an affected child given that the father is Black. Targeted testing of the father after the child's birth confirms that he is also a carrier of cystic fibrosis. The parents state that they would have never had children had they known the risk for cystic fibrosis.
The counselor's actions are BEST categorized as which of the following?
Question 7
Scenario: A 4-year-old girl with Rett syndrome presents for an initial consultation. The genetic counselor plans to refer to a multidisciplinary neurogenetics clinic that is located in a separate academic hospital 2 hours away. The patient agrees to the referral.
Under HIPAA, what is required regarding the transfer of records?
Question 8
Scenario: An investigator is submitting an IRB for a research project involving adult patients who did not complete their education beyond the 8th grade.
This population would be offered special protections under which of the following regulations?
Question 9
Scenario: A 32-year-old woman with a family history of colon cancer and a known pathogenic variant in MSH2 presents for follow up. She desires genetic testing for MSH2 for her 3-year-old daughter, who is asymptomatic and developing normally.
Which of the following ethical principles is most important to discuss with this patient regarding the testing of her daughter for the MSH2 variant?
Question 10
Scenario: A researcher is conducting a study on pain management and tells a hospitalized patient: "If you don't participate in this study, I cannot guarantee that your doctor will continue to provide your current pain medication regimen."
This scenario is BEST characterized as:
Question 11
Scenario: A 23-year-old man with 22q11.2 deletion syndrome is diagnosed with schizophrenia. His symptoms persist despite undergoing standard medical treatment. His psychiatrist, who is the lead investigator in a Phase II, open-label study exploring the effects of electroconvulsive therapy for patients with treatment-resistant schizophrenia, is enthusiastic about the potential benefits of this study. The psychiatrist discusses the study with the patient, who then agrees to enroll in the hope that this new treatment approach will alleviate his symptoms.
What is the most significant ethical concern associated with the patient enrolling in this study?
Question 12
Scenario: The sales director of a genetic sequencing company offers to give a seminar for CEU credit on long read sequencing to your department, which is part of a large academic medical center. As an incentive for participation, the company is offering branded sweatshirts to anyone who attends this seminar.
How should you respond to the company's offer?
Question 13
Scenario: A genetic counselor enters into an agreement with a new genetic testing laboratory. She receives a $20 gift card from this laboratory for each genetic test that she orders and sends to this laboratory.
This activity is prohibited under which of the following laws?
Question 14
Scenario: A patient is seeking genetic counseling for the purposes of embryo sex selection. The genetic counselor is not comfortable facilitating genetic testing for this purpose.
What should the genetic counselor do?